1
NSG 5544 EXAM 2 (SOUTH COLLEGE) NEWEST
EXAM FULL PACKAGE QUESTIONS ANSWERS AND
RATIONALES 2026-27 LATEST UPDATED VERSION
INSTANT DOWNLOAD PDF..!!
INTRODUCTION
The NSG 5544 Exam 2 (South College) is a critical milestone assessment for advanced
practice nursing students specializing in adult-gerontology primary care. This exam evaluates
rigorous clinical reasoning, pathophysiological application, and evidence-based
pharmacotherapeutic management of acute and chronic conditions commonly encountered
in the adult population. Key focus areas include advanced cardiovascular management,
complex renal alterations, pulmonary mechanics, endocrine management, and preventative
screening protocols. Facing this exam requires more than rote memorization; students must
interpret complex laboratory matrices, manage multi-drug titrations, and differentiate
target-organ damage from transient presentations. This practice question bank delivers
highly advanced, scenario-based multiple-choice questions designed to mirror the exact
cognitive complexity and structural blueprints of the official examination. By thoroughly
reviewing these clinical vignettes and detailed rationales, students will build the diagnostic
confidence, pharmacological acumen, and test-taking endurance necessary to achieve
mastery and pass on their very first attempt.
CORE DOMAINS TESTED
1. Advanced Cardiovascular Management: Pathophysiology, diagnostic stratification,
and multi-drug titration regimens for hypertension, dyslipidemia, heart failure, and
coronary disease.
2. Renal & Endocrine Alterations: Management of Chronic Kidney Disease (CKD) stages
1–4, diabetic nephropathy, insulin/non-insulin glycemic titration, and metabolic
balance.
3. Pulmonology & Hematology: Diagnosis and therapeutic step-up strategies for COPD,
asthma, sleep apnea, anemia differentials, and coagulation disorders.
4. Evidence-Based Guidelines & Screening: Application of national guidelines
(ACC/AHA, ADA, KDIGO, GOLD) to secondary prevention, preventative screening, and
lifestyle modifications.
,2
Q1: A 64-year-old female patient with a history of Stage 3 Chronic Kidney
Disease (eGFR 42 mL/min/1.73m²) and long-standing Type 2 Diabetes presents
for a routine follow-up. Her blood pressure is 144/88 mmHg on her current
regimen of amlodipine 10 mg daily. Laboratory evaluation reveals a spot urine
albumin-to-creatinine ratio (UACR) of 340 mg/g. Which of the following is the
most appropriate next step in optimizing her pharmacotherapy to slow renal
progression?
A) Discontinue amlodipine and initiate hydrochlorothiazide 25 mg daily
B) Add lisinopril 10 mg daily while keeping amlodipine, and monitor serum
potassium and creatinine in 1–2 weeks
C) Increase amlodipine to 15 mg daily and add spironolactone 25 mg daily
D) Add matching therapy with a direct renin inhibitor to achieve a target blood
pressure of < 120/80 mmHg
Rationale: The correct answer is B. According to the KDIGO and ADA guidelines,
patients with diabetes, hypertension, and a UACR >= 300 mg/g should be
initiated on an ACE inhibitor or an ARB as first-line therapy because these
agents preferentially dilate the efferent arteriole, reducing intraglomerular
pressure and halting the progression of nephropathy. Discontinuing amlodipine
for a thiazide (Option A) is inappropriate because thiazides lose efficacy when
eGFR drops below 45, and amlodipine does not need to be stopped. Increasing
amlodipine (Option C) will not address the proteinuric pathomechanism, and
combining a direct renin inhibitor with another RAAS blocker (Option D) is
contraindicated due to a high risk of hyperkalemia and acute kidney injury.
Q2: A 52-year-old male with an unremarkable past medical history presents to
the clinic establishing care. His initial automated office blood pressure reads
146/92 mmHg. A repeat reading 15 minutes later shows 142/90 mmHg. He
reports that his home blood pressure machine usually shows numbers "in the
120s over 70s." Which of the following clinical steps is recommended by the
2017 ACC/AHA guidelines before establishing a formal diagnosis of
hypertension?
A) Schedule the patient for an immediate 12-lead electrocardiogram to rule out
,3
left ventricular hypertrophy
B) Initiate monotherapy with a low-dose thiazide diuretic and re-evaluate in 4
weeks
C) Prescribe 24-hour Ambulatory Blood Pressure Monitoring (ABPM) or
instruct on systematic Home Blood Pressure Monitoring (HBPM) to rule out
white-coat hypertension
D) Diagnose Stage 2 Hypertension immediately based on office readings and
recommend lifestyle modifications
Rationale: The correct answer is C. The 2017 ACC/AHA guidelines strongly
recommend the use of out-of-office blood pressure measurements (either
ABPM or systematic HBPM) to confirm a diagnosis of hypertension when there
is a documented discrepancy between office readings and patient-reported
home readings, suggesting potential white-coat hypertension. Initiating
therapy (Option B) or diagnosing immediately (Option D) without out-of-office
confirmation risks overtreating a normotensive individual. Ordering an ECG
(Option A) is a component of target-organ damage screening but does not
resolve the diagnostic ambiguity of the blood pressure readings themselves.
Q3: A 69-year-old male is evaluated for recent-onset exertional dyspnea.
Physical examination reveals a harsh, crescendo-decrescendo systolic murmur
loudest at the right upper sternal border, radiating directly into the carotid
arteries. The apical impulse is displaced laterally. Which of the following non-
invasive diagnostic modalities is the gold standard next step to quantify the
severity of this valvular lesion?
A) Transesophageal echocardiography (TEE) with contrast enhancement
B) Transthoracic echocardiography (TTE) with Doppler interrogation
C) Computed tomography (CT) angiography of the coronary arteries
D) Standard 12-lead electrocardiography combined with an exercise stress test
Rationale: The correct answer is B. The patient's clinical presentation—harsh
crescendo-decrescendo systolic murmur at the right upper sternal border
radiating to the carotids—is highly characteristic of aortic stenosis. A
Transthoracic Echocardiogram (TTE) with Doppler analysis is the standard, non-
invasive gold diagnostic tool utilized to measure the aortic valve area, mean
pressure gradients, and jet velocity to quantify severity. TEE (Option A) is
invasive and generally reserved when TTE windows are poor or to rule out
thrombi. CT angiography (Option C) evaluates coronary anatomy rather than
, 4
valvular dynamics. Exercise stress testing (Option D) is absolutely
contraindicated in patients with severe, symptomatic aortic stenosis due to the
high risk of syncope or sudden cardiac death.
Q4: A 58-year-old male presents with long-standing hypertension and a new
complaint of exertional dyspnea. Physical exam reveals an S4 gallop and trace
peripheral edema. EKG shows left ventricular hypertrophy (LVH). Which class of
antihypertensive agents is preferred to encourage reverse remodeling of the
myocardium?
A) Loop diuretics
B) Angiotensin Receptor Blockers (ARBs)
C) Alpha-1 receptor antagonists
D) Direct vasodilators
Rationale: The correct answer is B. ARBs or ACE inhibitors are preferred in
patients with LVH because blocking the renin-angiotensin-aldosterone system
directly halts and can reverse myocardial fibrosis and hypertrophy, unlike direct
vasodilators (Option D) which cause reflex tachycardia or alpha-blockers
(Option C) which do not carry the same robust class indications for myocardial
remodeling.
Q5: A 53-year-old female with Type 2 Diabetes is evaluated for recurrent
episodes of morning hypoglycemia. Her current regimen includes glimepiride 4
mg daily and metformin 1000 mg twice daily. Her HbA1c is 6.8%. Which of the
following is the most appropriate clinical modification?
A) Increase metformin to maximum doses
B) Discontinue glimepiride and consider an SGLT2 inhibitor or GLP-1 receptor
agonist
C) Add pioglitazone 15 mg daily
D) Instruct the patient to consume a high-carbohydrate snack before bedtime
Rationale: The correct answer is B. Glimepiride is a long-acting sulfonylurea
associated with a high risk of hypoglycemia, especially as tight glycemic targets
are approached. Transitioning to cardio-protective and weight-neutral agents
like SGLT2 inhibitors or GLP-1 agonists is preferred. High-carbohydrate snacks
(Option D) cause unnecessary caloric gain and worsen overall metabolic
control.
NSG 5544 EXAM 2 (SOUTH COLLEGE) NEWEST
EXAM FULL PACKAGE QUESTIONS ANSWERS AND
RATIONALES 2026-27 LATEST UPDATED VERSION
INSTANT DOWNLOAD PDF..!!
INTRODUCTION
The NSG 5544 Exam 2 (South College) is a critical milestone assessment for advanced
practice nursing students specializing in adult-gerontology primary care. This exam evaluates
rigorous clinical reasoning, pathophysiological application, and evidence-based
pharmacotherapeutic management of acute and chronic conditions commonly encountered
in the adult population. Key focus areas include advanced cardiovascular management,
complex renal alterations, pulmonary mechanics, endocrine management, and preventative
screening protocols. Facing this exam requires more than rote memorization; students must
interpret complex laboratory matrices, manage multi-drug titrations, and differentiate
target-organ damage from transient presentations. This practice question bank delivers
highly advanced, scenario-based multiple-choice questions designed to mirror the exact
cognitive complexity and structural blueprints of the official examination. By thoroughly
reviewing these clinical vignettes and detailed rationales, students will build the diagnostic
confidence, pharmacological acumen, and test-taking endurance necessary to achieve
mastery and pass on their very first attempt.
CORE DOMAINS TESTED
1. Advanced Cardiovascular Management: Pathophysiology, diagnostic stratification,
and multi-drug titration regimens for hypertension, dyslipidemia, heart failure, and
coronary disease.
2. Renal & Endocrine Alterations: Management of Chronic Kidney Disease (CKD) stages
1–4, diabetic nephropathy, insulin/non-insulin glycemic titration, and metabolic
balance.
3. Pulmonology & Hematology: Diagnosis and therapeutic step-up strategies for COPD,
asthma, sleep apnea, anemia differentials, and coagulation disorders.
4. Evidence-Based Guidelines & Screening: Application of national guidelines
(ACC/AHA, ADA, KDIGO, GOLD) to secondary prevention, preventative screening, and
lifestyle modifications.
,2
Q1: A 64-year-old female patient with a history of Stage 3 Chronic Kidney
Disease (eGFR 42 mL/min/1.73m²) and long-standing Type 2 Diabetes presents
for a routine follow-up. Her blood pressure is 144/88 mmHg on her current
regimen of amlodipine 10 mg daily. Laboratory evaluation reveals a spot urine
albumin-to-creatinine ratio (UACR) of 340 mg/g. Which of the following is the
most appropriate next step in optimizing her pharmacotherapy to slow renal
progression?
A) Discontinue amlodipine and initiate hydrochlorothiazide 25 mg daily
B) Add lisinopril 10 mg daily while keeping amlodipine, and monitor serum
potassium and creatinine in 1–2 weeks
C) Increase amlodipine to 15 mg daily and add spironolactone 25 mg daily
D) Add matching therapy with a direct renin inhibitor to achieve a target blood
pressure of < 120/80 mmHg
Rationale: The correct answer is B. According to the KDIGO and ADA guidelines,
patients with diabetes, hypertension, and a UACR >= 300 mg/g should be
initiated on an ACE inhibitor or an ARB as first-line therapy because these
agents preferentially dilate the efferent arteriole, reducing intraglomerular
pressure and halting the progression of nephropathy. Discontinuing amlodipine
for a thiazide (Option A) is inappropriate because thiazides lose efficacy when
eGFR drops below 45, and amlodipine does not need to be stopped. Increasing
amlodipine (Option C) will not address the proteinuric pathomechanism, and
combining a direct renin inhibitor with another RAAS blocker (Option D) is
contraindicated due to a high risk of hyperkalemia and acute kidney injury.
Q2: A 52-year-old male with an unremarkable past medical history presents to
the clinic establishing care. His initial automated office blood pressure reads
146/92 mmHg. A repeat reading 15 minutes later shows 142/90 mmHg. He
reports that his home blood pressure machine usually shows numbers "in the
120s over 70s." Which of the following clinical steps is recommended by the
2017 ACC/AHA guidelines before establishing a formal diagnosis of
hypertension?
A) Schedule the patient for an immediate 12-lead electrocardiogram to rule out
,3
left ventricular hypertrophy
B) Initiate monotherapy with a low-dose thiazide diuretic and re-evaluate in 4
weeks
C) Prescribe 24-hour Ambulatory Blood Pressure Monitoring (ABPM) or
instruct on systematic Home Blood Pressure Monitoring (HBPM) to rule out
white-coat hypertension
D) Diagnose Stage 2 Hypertension immediately based on office readings and
recommend lifestyle modifications
Rationale: The correct answer is C. The 2017 ACC/AHA guidelines strongly
recommend the use of out-of-office blood pressure measurements (either
ABPM or systematic HBPM) to confirm a diagnosis of hypertension when there
is a documented discrepancy between office readings and patient-reported
home readings, suggesting potential white-coat hypertension. Initiating
therapy (Option B) or diagnosing immediately (Option D) without out-of-office
confirmation risks overtreating a normotensive individual. Ordering an ECG
(Option A) is a component of target-organ damage screening but does not
resolve the diagnostic ambiguity of the blood pressure readings themselves.
Q3: A 69-year-old male is evaluated for recent-onset exertional dyspnea.
Physical examination reveals a harsh, crescendo-decrescendo systolic murmur
loudest at the right upper sternal border, radiating directly into the carotid
arteries. The apical impulse is displaced laterally. Which of the following non-
invasive diagnostic modalities is the gold standard next step to quantify the
severity of this valvular lesion?
A) Transesophageal echocardiography (TEE) with contrast enhancement
B) Transthoracic echocardiography (TTE) with Doppler interrogation
C) Computed tomography (CT) angiography of the coronary arteries
D) Standard 12-lead electrocardiography combined with an exercise stress test
Rationale: The correct answer is B. The patient's clinical presentation—harsh
crescendo-decrescendo systolic murmur at the right upper sternal border
radiating to the carotids—is highly characteristic of aortic stenosis. A
Transthoracic Echocardiogram (TTE) with Doppler analysis is the standard, non-
invasive gold diagnostic tool utilized to measure the aortic valve area, mean
pressure gradients, and jet velocity to quantify severity. TEE (Option A) is
invasive and generally reserved when TTE windows are poor or to rule out
thrombi. CT angiography (Option C) evaluates coronary anatomy rather than
, 4
valvular dynamics. Exercise stress testing (Option D) is absolutely
contraindicated in patients with severe, symptomatic aortic stenosis due to the
high risk of syncope or sudden cardiac death.
Q4: A 58-year-old male presents with long-standing hypertension and a new
complaint of exertional dyspnea. Physical exam reveals an S4 gallop and trace
peripheral edema. EKG shows left ventricular hypertrophy (LVH). Which class of
antihypertensive agents is preferred to encourage reverse remodeling of the
myocardium?
A) Loop diuretics
B) Angiotensin Receptor Blockers (ARBs)
C) Alpha-1 receptor antagonists
D) Direct vasodilators
Rationale: The correct answer is B. ARBs or ACE inhibitors are preferred in
patients with LVH because blocking the renin-angiotensin-aldosterone system
directly halts and can reverse myocardial fibrosis and hypertrophy, unlike direct
vasodilators (Option D) which cause reflex tachycardia or alpha-blockers
(Option C) which do not carry the same robust class indications for myocardial
remodeling.
Q5: A 53-year-old female with Type 2 Diabetes is evaluated for recurrent
episodes of morning hypoglycemia. Her current regimen includes glimepiride 4
mg daily and metformin 1000 mg twice daily. Her HbA1c is 6.8%. Which of the
following is the most appropriate clinical modification?
A) Increase metformin to maximum doses
B) Discontinue glimepiride and consider an SGLT2 inhibitor or GLP-1 receptor
agonist
C) Add pioglitazone 15 mg daily
D) Instruct the patient to consume a high-carbohydrate snack before bedtime
Rationale: The correct answer is B. Glimepiride is a long-acting sulfonylurea
associated with a high risk of hypoglycemia, especially as tight glycemic targets
are approached. Transitioning to cardio-protective and weight-neutral agents
like SGLT2 inhibitors or GLP-1 agonists is preferred. High-carbohydrate snacks
(Option D) cause unnecessary caloric gain and worsen overall metabolic
control.
